Danaher (DHR) Q1 2026 Earnings Call Highlights
Danaher (DHR) reported Q1 2026 total sales of $6 billion, with core revenue growth of 0.5% year-over-year. The company faced a 2.5% headwind from respiratory revenue, while biotechnology and bioprocessing equipment orders showed positive growth.
Tickers: $DHR
Topics: Bioprocessing Biotechnology Cepheid Diagnostics Earnings Call Revenue Growth